Ronald L. Gibson
Department of Pediatrics
University of Washington/Children's Hospital & Regional Medical Center
Seattle
WA 98105-0371
USA
Name/email consistency: high
- Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Gibson, R.L., Emerson, J., Mayer-Hamblett, N., Burns, J.L., McNamara, S., Accurso, F.J., Konstan, M.W., Chatfield, B.A., Retsch-Bogart, G., Waltz, D.A., Acton, J., Zeitlin, P., Hiatt, P., Moss, R., Williams, J., Ramsey, B.W. Pediatr. Pulmonol. (2007)
- Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Gibson, R.L., Retsch-Bogart, G.Z., Oermann, C., Milla, C., Pilewski, J., Daines, C., Ahrens, R., Leon, K., Cohen, M., McNamara, S., Callahan, T.L., Markus, R., Burns, J.L. Pediatr. Pulmonol. (2006)
- Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Gibson, R.L., Emerson, J., McNamara, S., Burns, J.L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., Konstan, M.W., Moss, R., Retsch-Bogart, G., Wagener, J., Waltz, D., Wilmott, R., Zeitlin, P.L., Ramsey, B. Am. J. Respir. Crit. Care Med. (2003)









